High levels of ATF4 in patients with breast cancer were associated with poorer overall survival and relapse-free survival (Figure 3C, D) when patient data were split by upper quartile of expression compared to the lower three quartiles, as well as when patient data were split by median expression (data not shown). Here, ATF4 is linked to breast cancer.